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Abstract
Context. Systematic data on the care of people dying with COVID-19 are scarce.
Objectives. To understand the response of and challenges faced by palliative care services during the COVID-19 pandemic,
and identify associated factors.
Methods. We surveyed palliative care and hospice services, contacted via relevant organizations. Multivariable logistic regres-
sion identified associations with challenges. Content analysis explored free text responses.
Results. A total of 458 services responded; 277 UK, 85 rest of Europe, 95 rest of the world; 81% cared for patients with
suspected or confirmed COVID-19, 77% had staff with suspected or confirmed COVID-19; 48% reported shortages of Per-
sonal Protective Equipment (PPE), 40% staff shortages, 24% medicines shortages, 14% shortages of other equipment. Serv-
ices provided direct care and education in symptom management and communication; 91% changed how they worked.
Care often shifted to increased community and hospital care, with fewer admissions to inpatient palliative care units. Fac-
tors associated with increased odds of PPE shortages were: charity rather than public management (OR 3.07, 95% CI 1.81
−5.20), inpatient palliative care unit rather than other settings (OR 2.34, 95% CI 1.46−3.75). Being outside the UK was
associated with lower odds of staff shortages (OR 0.44, 95% CI 0.26−0.76). Staff described increased workload, concerns
for their colleagues who were ill, whilst expending time struggling to get essential equipment and medicines, perceiving
they were not a front-line service.
Conclusion. Palliative care services were often overwhelmed, yet felt ignored in the COVID-19 response. Palliative
care needs better integration with health care systems when planning and responding to future epidemics/pandemics.
J Pain Symptom Manage 2021;000:1−11. © 2021 The Authors. Published by Elsevier Inc. on behalf of American Academy of Hospice
and Palliative Medicine. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
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Key message
Palliative care teams actively supported symptom-
atic and dying patients with COVID-19, and their
families. However, they felt ignored by national and
international pandemic responses and often lacked
equipment, staff, medicines, integration and
recognition.
Introduction
COVID-19 evolved from a mystery illness to a pan-
demic in 93 days, overwhelming services in many coun-
tries.1 The World Health Organization rapidly issued
guidance on maintaining essential health services during
the pandemic, highlighting prevention, maternity, emer-
gency care and chronic diseases, without mention of pal-
liative care.2 COVID-19 has an overall case fatality ratio
between 1% and 4%;3 by January 2021 there were over
2.1 million confirmed COVID-19 deaths worldwide.4
Palliative care is multidisciplinary, holistic and person-
centered treatment, care and support for people with
life-limiting illness, and those important to them, such as
family and friends. It is recommended in respiratory5,6
and infectious diseases,7 and in recent guidance from
the European Respiratory Society in COVID-19.8,9 In the
COVID-19 pandemic, palliative care has an important
role in ensuring symptom control, training of nonspe-
cialists in symptom management and care of dying
patients, compassionate communication, psychosocial
support for patients, carers and health care professio-
nals, advance care planning and bereavement sup-
port,8,10 supporting patients wherever they want to be
cared for (Table 1).11
The only review published on the role and response
of palliative care and hospice services during pandem-
ics included 10 observational studies12 from single units
or countries: West Africa, Taiwan, Hong Kong, Singa-
pore, the U.S. (a simulation), and Italy (the only one
considering COVID-19). The review concluded hospice
and palliative care services are essential in the response
to COVID-19 but systematic data are urgently needed
to inform how to improve care for those who are likely
to die, and/or have severe symptoms.
Palliative care services are often managed separately
from other medical services and may be exceptionally
vulnerable to disruption in pandemics as they often
rely on charity funding. During the COVID-19 pan-
demic there were media reports of acute shortages of
Personal Protective Equipment (PPE) and medicines
that limited care.13 There is little systematic data about
these situations.12,14 This study aimed to understand
the response of and challenges faced by palliative care
services during the COVID-19 pandemic, and to iden-
tify factors associated with challenges experienced, in
particular shortages of equipment, medicines and staff.
We tested two a priori null hypotheses:
- There are no differences in shortages between
services with different management types (e.g.,
charity and public)
- There are no differences in shortages between set-
tings; e.g., between hospital based and nonhospital
based; or community and noncommunity settings.
Methods
Study Design and Participants
CovPall is a multicenter multinational observational
study of palliative care during the COVID-19 pan-
demic. This paper reports an on-line survey of palliative
care services, the first main component of CovPall. The
survey opened on April 23rd, 2020 and closed July 31st,
2020. The survey received ethical (Institutional Review
Board) approval from King’s College London Research
Table 1
Palliative Care Services Provided in Different Settings
Palliative Care Settinga Description of Setting
Inpatient palliative care unit Provides specialist inpatient palliative care. It can be a ward within, or adjacent to, a hospital, or a
free standing building. In some countries, it is called an inpatient hospice.
Hospital palliative care team Provides specialist palliative care advice and support to other clinical staff, patients and their
families and carers in the hospital environment. They offer formal and informal education and
liaise with other services in and out of the hospital.
Home palliative care team Provides specialist palliative care to patients who need it at home, or in care homes or residential
homes, and support their families and carers. They also provide specialist advice to general
practitioners, family doctors and nurses caring for the patients.
Home nursing Provides intensive home nursing care for the patient at home, sometimes referred to as hospice or
hospital at home, often supporting patients whose care needs are such that without this they
would be admitted to an inpatient palliative care unit or hospital.
aPalliative care and hospice services have multiprofessional teams of dedicated staff trained in palliative care, comprising doctors, nurses, and often social workers
and therapists. They provide expertise in pain and symptom management, holistic and psychosocial care, decision making, advance care planning, end of life care
and often bereavement support. They include support in the settings described above (one service may provide support in one or more settings).
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Ethics committee (LRS-19/20-18541); study sponsor:
King’s College London, co-sponsor: King’s College
Hospital NHS Foundation Trust, registered ISRCTN
16561225. It is reported according to STROBE,15
CHERRIES16 and MORECARE17statements.
Inclusion criteria: Any palliative care service
(Table 1)11; caring for adults and/or children; managed
by charity, public, private or other sector. Exclusion crite-
ria: not a specialist palliative care/hospice service,e.g., no
staff with specific expertise/training in palliative care.
Procedures and Questionnaire
Services were identified and contacted through
national and multinational palliative care and hospice
organizations (supplementary file, box S1) and pro-
vided with a link to the on-line survey and the partici-
pant information sheet. Completion indicated consent.
The questionnaire was developed and piloted, building
on an earlier survey of Italian hospices,14 adding ques-
tions on the impact of and response to COVID-19. It
was intended to be brief, taking »30 minutes to com-
plete. Free-text comments were invited using extension
(e.g., other, please specify), expansion (e.g., elaborat-
ing on closed responses by giving details or reasons),
and general (e.g., any other comments) approaches18
(see Appendix II). Free text responses were planned to
shed light on the closed text responses, provide a
richer context with specific examples, and as a “safety
net” to identify issues which might have been missed by
the closed questions. Data were anonymized before
analysis.
Sample Size and Analysis
We aimed to have responses from >390 services,
»130 inpatient palliative care units, 130 hospital pallia-
tive care teams, and 130 home palliative care teams.
Subgroups of this size (>105) are sufficient to detect
differences with effect sizes of 0.35, using x2 (P < .05,
df = 5, power 80%).
After removing duplicate and ineligible entries all
available data were analyzed. We report completion
rate and summary statistics. Missing data were not
imputed. We used contingency tables, x2 tests, correla-
tions and multivariable logistic regression to explore
relationships between variables (using SPSS v26,
STATA v16). We preselected four dependent variables
critical to delivering care, presence or not of shortages
of: PPE, staff, medicines, and other equipment (such as
syringe drivers). Independent variables were: country/
region, charity or public management, settings (in-
patient palliative care unit, hospital palliative care
team, home palliative care team, home nursing), expe-
riences with COVID-19 and level of busyness; criteria
for inclusion in multiple regression analyses was P < .10
in univariable analysis. We excluded variables exhibit-
ing collinearity with independent variables already
included if the variance inflation factor >10 or chi-
square test, P < .05.
Free text comments were explored in Excel using
content analysis to understand the impact of COVID-
19 and the strategies, enablers and actions deployed by
services.
Results
In total, 489 questionnaires were commenced, 477
completed (completion rate 97.5%); of these 15 were
duplicates and 2 triplicates of entries with the same
name/email; 2 were invalid being from one researcher
without a palliative care service, leaving 458 valid
responses: 277 UK, 85 rest of Europe, 95 rest of the
world, 1 missing country (Table 2; supplementary
Table S1). Services were usually publicly (204, 46.4%),
or charity managed (192, 43.6%); 19 (4.3%) were pri-
vately managed, 25 (5.7%) other; 18 missing. Charity
managed services reported less integration with
national health services (mean [SD]: 67.82 [19.75])
compared to publicly managed services (mean [SD]:
75.10 [19.75]), (mean difference [95% CI]: 7.28 [3.24
−11.33]; P < .001). Overall, 261 services provided inpa-
tient palliative care units, 261 home care teams, 217
hospital palliative care teams, and 119 home nursing
teams. Many services offered care in more than one set-
ting (supplementary Table S2).
Overall Impact of COVID-19 on Palliative and Hospice
Services
Of all responding services, 91% changed how they
worked as a result of COVID-19; 77% had staff who had
suspected or confirmed cases of COVID-19. 81% of
services had cared for patients with suspected or con-
firmed COVID-19, or both; of these, three main groups
were cared for: patients with pre-existing illness or mor-
bidities who were severely ill or dying from COVID-19
not previously known to palliative care (70% of serv-
ices); patients dying from COVID-19 already known to
palliative care services (47%); and patients severely ill
or dying from COVID-19 but without pre-existing ill-
ness or morbidities (37%) (Table 2, supplementary
Table S1).
Activities and Changes in Services
Free text responses revealed that inpatient palliative
care units reported reduced activity; patients who did
not have COVID-19 did not want to be admitted for
fear of contracting the infection. There was increased
home and hospital palliative care team activity. Assis-
tance from volunteers plummeted; of responding serv-
ices who used volunteers, 79% used them much less.
Many volunteers were from older age groups and
therefore high risk. Other activities and changes
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Table 2
Characteristics of Responding Palliative Care and Hospice Services by Region
Rest of the world (n = 95)









Management type (n/N, %)a
Charitable / nonprofit 143/262 (54.6%) 23/85 (27.1%) 5/17 (29.4%) 6/17 (35.3%) 14/58 (24.1%) 192/440 (43.6%)b
Public 103/262 (39.3%) 51/85 (60%) 8/17 (47.1%) 6/17 (35.3%) 36/58 (62.1%) 204/440 (46.4%)b
Private 1/262 (0.4%) 9/85 (10.6%) 2/17 (11.8%) 5/17 (29.4%) 2/58(3.4%) 19/440 (4.3%)b
Other 15/262 (5.7%) 2/85 (2.4%) 2/17 (11.8%) - 6/58 (10.3%) 25/440 (5.7%)b
Missing 15 - - 2 1 18
Setting (n/N, %)
Inpatient PC unit 168/277 (60.6%) 44/85 (51.8%) 8/17 (47.1%) 6/19 (31.6%) 34/59 (57.6%) 261/458 (57%)b
Hospital PC team 135/277 (48.7%) 26/85 (30.6%) 9/17 (52.9%) 10/19 (52.6%) 37/59 (62.7%) 217/458 (47.4%)b
Home PC team 160/277 (57.8%) 47/85 (55.3%) 10/17 (58.8%) 9/19 (47.4%) 34/59 (57.6%) 261/458 (57%)b
Home nursing 92/277 (33.2%) 15/85 (17.6%) 1/17 (5.9%) 4/19 (21.1%) 7/59 (11.9%) 119/458 (26%)b
Total 277 85 17 19 59 458b
Experience with suspected or confirmed COVID-19
Services with confirmed or suspected COVID-19 cases (n/N, %)a 248/264 (93.9%) 60/83 (72.3%) 9/17 (52.9%) 7/17 (41.2%) 33/58 (56.9%) 358/440 (81.4%)b
Missing 13 2 - 2 1 18
Approximate number of confirmed or suspected COVID-19 cases per
service
Median (Q1, Q3) 25.5 (7, 70) 15 (4.5, 35.5) 3 (2, 70) 8 (2, 20) 6 (2, 11) 16 (5.5, 56)
Total 234 61 9 7 33 345
Services with confirmed or suspected COVID-19 cases (n/N, %)
In-patient PC unit 146/158 (92.4%) 30/43 (69.8%) 3/8 (37.5%) 3/5 (60%) 20/34 (58.8%) 203/249 (81.5%)b
Hospital PC team 127/129 (98.4%) 20/26 (76.9%) 5/9 (55.6%) 4/9 (44.4%) 26/36 (72.2%) 182/209 (87.1%)
Home PC team 143/151 (94.7%) 35/46 (76.1%) 5/10 (50%) 3/7 (42.9%) 17/34 (50%) 204/249 (81.9%)b
Home nursing 82/87 (94.3%) 7/13 (53.8%) 0/1 (0%) 0/3 (0%) 5/7 (71.4%) 94/111 (84.7%)
Severity of disease in patients with suspected or confirmed COVID-19
(n/N, %)
Severely ill or dying due mainly to COVID-19 112/248 (45.2%) 13/60 (21.7%) 1/9 (11.1%) 0/7 5/33 (15.2%) 131/358 (36.6%)b
Pre-existing illnesses/comorbidities as well as COVID-19 who are
severely ill or dying
192/248 (77.4%) 34/60 (56.7%) 3/9 (33.3%) 5/7 (71.4%) 15/33 (45.5%) 250/358 (69.8%)b
Patients known to service already who now have COVID-19 129/248 (52%) 21/60 (35%) 3/9 (33.3%) 2/7 (28.6%) 12/33 (36.4%) 168/358 (46.9%)b
Services with staff with suspected or confirmed COVID-19 (n/N, %)a 238/262 (90.8%) 55/83 (66.3%) 4/16 (25%) 7/17 (41.2%) 30/58 (51.7%) 335/437 (76.7%)b
Missing 15 2 1 2 1 21
Type of staff with suspected or confirmed COVID-19 (n/N, %)
Nurses 224/238 (94.1%) 51/55 (92.7%) 3/4 (75%) 7/7 (100%) 22/30 (73.3%) 308/335 (91.9%)b
Physicians 161/238 (67.6%) 32/55 (58.2%) 2/4 (50%) 3/7 (42.9%) 15/30 (50%) 214/335 (63.9%)b
Allied health professionals, managed 92/238 (38.7%) 11/55 (20%) 3/4 (75%) 1/7 (14.3%) 7/30 (23.3%) 115/335 (34.3%)b
Reception/administrative staff 74/238 (31.1%) 9/55 (16.4%) 0/4 2/7 (28.6%) 3/30 (10%) 88/335 (26.3%)b
Managers 69/238 (29%) 8/55 (14.5%) 0/4 1/7 (14.3%) 0/30 78/335 (23.3%)b
Others 48/238 (20.2%) 5/55 (9.1%) 1/4 (25%) 0/7 4/30 (13.3%) 58/335 (17.3%)b
Other support (n, %)
Services that have encountered patients or families with COVID-19
who are from black and minority ethnic groups (n/N, %)a
93/254 (36.6%) 16/76 (21.1%) 3/16 (18.8%) 5/16 (31.3%) 15/56 (26.8%) 132/419 (31.5%)b
Missing 23 9 1 3 3 39
Shortages (n, %)








































































































































































































































































































































































































































































































































































































































Missing 19 10 2 2 5 39b
PPE shortages in the last 7 days (n/N, %)c 50/127 (39.4%) 7/38 (18.4%) 7/9 (77.8%) 5/6 (83.3%) 6/19 (31.6%) 75/199 (37.7%)
Missing or not applicabled 150 47 8 13 40 259b
Key medicines shortages (n/N, %)a 63/255 (24.7%) 19/73 (26%) 4/15 (26.7%) 4/17 (23.5%) 11/54 (20.4%) 101/414 (24.4%)
Missing 22 12 2 2 5 44b
Key medicines shortages in the last 7 days (n/N, %)c 28/63 (44.4%) 3/18 (16.7%) 4/4(100%) 4/4 (100%) 6/11 (54.5%) 45/100 (45%)
Missing or not applicabled 214 67 13 15 48 358b
Equipment shortages (e.g. syringe drivers) (n/N, %)a 45/256 (17.6%) 3/73 (4.1%) 4/14 (28.6%) 2/17 (11.8%) 2/54 (3.7%) 56/414 (13.5%)
Missing 21 12 3 2 5 44b
Equipment shortages in the last 7 days (N/n, %)c 19/42 (45.2%) 1/3 (33.3%) 3/3 (100%) 2/2 (100%) 2/2 (100%) 27/52 (51.9%)
Missing or not applicabled 235 82 14 17 57 406b
Staff shortages (n, %)a 117/255 (45.9%) 26/75 (34.7%) 4/14 (28.6%) 6/16 (37.5%) 13/54 (24.1%) 166/414 (40.1%)
Missing 22 10 3 3 5 44b
Staff shortages in the last 7 days (N/n, %)c 61/114 (53.5%) 9/26 (34.6%) 3/4 (75%) 5/5 (100%) 5/13 (38.5%) 83/162 (51.2%)
Missing or not applicabled 163 59 13 14 46 296b
Note: UK = United Kingdom, Rest of Europe excludes UK, LIC = low-income countries, LMIC = lower middle-income countries, UMIC = upper middle-income countries, HIC = high-income countries, NHS = National Health
Service, PC = palliative care.
aN of value and valid N denominator are provided. Percentages are of valid values, unless otherwise stated. Number of missing responses for each category is provided.
bIncludes data from the one missing country.
cResponse for “yes” and “sometimes” both coded as “yes”.























































































medicines, and 14% shortages of other equipment,
commonly battery operated syringe drivers (Table 2).
PPE Shortages. Being charity managed was associated
with greater likelihood of PPE shortages compared
with publicly managed (OR 3.07, 95% CI 1.81−5.20; P
< .001) (Table 3, Fig. 2). Inpatient palliative care units
were more likely to have PPE shortages compared to
other settings (OR 2.34, 95% CI 1.46−3.75; P < .001).
Home nursing had high shortages of PPE (70%, Fig. 2)
compared with other settings. Home nursing was most
commonly provided by services also providing inpatient
palliative care (see supplementary table S2); this may
be confounding the relationship between inpatient pal-
liative care units and PPE shortages. Hospital palliative
care teams were less likely to have PPE shortages com-
pared to other settings (OR 0.51, 95% CI 0.32−0.82; P
= .005). During the 7 days before completion of the sur-
vey, shortages were more common in the UK than in
Europe (Table 2, Fig.2). In free text fields, shortages
were reported most commonly for masks (filtering
facepiece, FFP2, FFP3), FIT testing kits for FFP3 masks,
hospital scrubs, aprons, gloves, face shields, long sleeve
gowns, hand gels, goggles, and eye protection.
Staff Shortages. Staff shortages were higher in the UK
(46%) than other countries (27%) (Fig. 2, regression
analysis OR 0.44, 95% CI 0.26−0.76; P = .003, UK vs.
rest of the world). Other factors were not significantly
associated with staff shortages in regression analysis.
Free text comments described shortages in specialist
palliative care teams, of doctors (consultants, specialty
doctors, middle grade, and junior doctors), nurses
(advanced practitioners, clinical nurse specialists, com-
munity nurses, community palliative care nurses,
Table 3
Multivariate Logistic Regression: Factors Associated with
Shortages
Multivariate logistic Regression: factors associated with PPE
shortages
Variables Odds Ratio CIlower CIupper P value
Unit management type
Public Ref
Charitable 3.07 1.81 5.20 P < .001








Yes 0.51 0.32 0.82 P = .005
Multivariate logistic regression: factors associated with staff
shortages
Variables Odds ratio CIlower CIupper P value
Country
UK Ref
Rest of Europe 0.63 0.37 1.07 .09
Rest of the world 0.44 0.26 0.76 .003
Multivariate logistic regression: factors associated with other
equipment shortages




Yes 0.35 0.18 0.65 .001
Country
UK Ref
Rest of Europe 0.15 0.04 0.51 .002
Rest of the world 0.46 0.20 1.08 .07
Level of busyness
About the same Ref
A lot more busy 10.81 3.10 37.71 <.001
Slightly more busy 5.41 1.48 19.76 .01
Slightly less busy 3.24 0.81 12.89 .10
Much less busy 1.32 0.21 8.34 .77
Note: No multivariate logistic regression analysis could be carried out for medi-
cines shortages because only one variable (inpatient palliative care unit) was
relevant from the univariable analysis.
Ref: Reference category, CI = confidence interval.
Fig. 2. Percentage of shortages by management type, world regions and settings, derived from responses to closed format questions.
ARTICLE IN PRESS
6 Vol. 00 No. 00 xxx 2021Oluyase et al.
registered general nurses, ward managers), allied
health professionals (healthcare assistants, occupa-
tional therapists, pharmacists, pharmacy assistants,
physiotherapists, social workers), administrative and
housekeeping staff.
Medicines Shortages. The top three medicine shortages
reported in free text comments were: levomeproma-
zine, midazolam (used for symptoms of agitation and
delirium) and alfentanil (used for pain and breathless-
ness, commonly used in the UK in severe renal
impairment, when morphine is contra-indicated).
Shortages of medicines affected 20%−27% of settings
(Fig.2). Only one variable (inpatient palliative care
unit) met our criteria for inclusion from the univari-
able analysis (at P = .07), so multiple regression analysis
was not attempted.
Other Equipment Shortages. Free text responses
described shortages or delays in access to other equip-
ment, especially syringe drivers/pumps, syringe pump
lines, butterfly needles and tympanic thermometer cov-
ers. Inpatient palliative care units were less likely to
have other equipment shortages compared to other
settings (OR 0.35, 95% CI 0.18−0.65; P = .001, Fig. 2).
When compared to the UK, being elsewhere in Europe
was associated with lower odds of other equipment
shortages (OR 0.15, 0.04−0.51; P = .002).
Response to Shortages
Free text comments revealed that services expended
huge efforts to procure PPE, some deployed staff to
find PPE as their main role. Services contacted local
vets, schools, dentists, universities, hospitals, businesses,
health services, national supply lines, the government,
professional organizations and the wider public. Some
made their own supplies, crowd sourced and ran social
media campaigns (Fig. 3).
In response to staff shortages, multidisciplinary full
and part-time staff worked longer hours, extra shifts and
flexibly collaborated. Services reduced hospice beds;
day-care services were closed and staff were deployed to
the community. Bank, research, agency and nonclinical
staff were used. New staff were rapidly trained. Some
services drafted emergency staffing plans. Mental health
support was provided. As one service lead summarized
“the impact of the multiple 'threats' to self [that staff
felt] should not be underestimated” as the staff are wor-
ried about themselves, their families, their colleagues,
their patients, working in unfamiliar areas and
experiencing “. . .[Acute Respiratory Disease Syndrome]
as a distressing mode of death.”
In response to medicine shortages, services con-
tacted local services and pharmacists (Fig. 3). Some
used alternative medicines even as first line, alternative
strengths (lower or higher concentrations), or reduced
the numbers of vials when prescribing home medica-
tions. For example, for shortages of levomepromazine,
services prioritized it for agitation, using alternatives
for controlling nausea and vomiting. Services intro-
duced temporary changes in Standard Operating Pro-
cedures (SOP) and developed new SOPs on drug
reuse. The positive response and active involvement of
local teams enabled the adaptation, as one service
reported ‘. . .staff [were] very engaged and responsive
to our requests for frequent change of practice’.
In response to shortages of other equipment, serv-
ices tried to get loans from other teams and settings
(Fig. 3). The teams explored alternative ways to man-
age symptoms and administer medication to require
less use of limited equipment. For example, faced with
a shortage of syringe drivers (small, portable, battery
powered infusion pumps suitable to give medicines for
Fig. 3. Strategies, enablers, specific actions and quotes about shortages, derived from free text responses.
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breathlessness, pain and agitation), services carried out
risk assessments, programmed alternative pumps, such
as 50 ml infusion devices, gave four hourly subcutane-
ous injections, or considered using transdermal
patches rather than subcutaneous infusions.
Discussion
We report the first multinational survey on the
response of and challenges to palliative care services
during the COVID-19 pandemic. Across all settings pal-
liative care services rapidly changed, increasing the vol-
ume and nature of provision, caring for people with
COVID-19, as well as for existing patients. Patients
dying from and with severe symptoms due to COVID-
19 were in three main categories: patients with underly-
ing conditions and/or multimorbid disease not previ-
ously known to palliative care, patients already known
to palliative care services, and patients previously
healthy, who were now dying from COVID-19. Palliative
care became exceptionally busy, especially in areas with
high COVID-19 prevalence. Care shifted to community
and hospital support from inpatient palliative care
units. Staff were also infected by COVID-19. Services
experienced multiple shortages of equipment, includ-
ing PPE, staff and medicines that limited their ability to
respond. Our two prior null hypotheses were rejected.
There were differences in shortages between services
with different management types and between settings.
Palliative care staff responded dynamically; they pro-
vided care directly to patients and families across hospi-
tals and the community, supported other clinical staff
through training, symptom management, communica-
tion and care guidance, supported decision making
and filled gaps in care. They used their expertise to
propose strategies to deal with medicines shortages.
These contributions have been vital; clinicians with lim-
ited or no palliative care experience had to provide
end of life care to patients and support their fami-
lies.8,9. Palliative care clinicians adapted and innovated
quickly.19, possibly helped by prior experience with
patients with different diseases and with multimorbid-
ity. Palliative care puts the person before their disease
wherever they are cared for: it is neither disease nor set-
ting specific. The symptoms and problems of severe
COVID-19 are commonly breathlessness and agita-
tion,20,21 both familiar to palliative care clinicians. Cur-
rent case reports suggest that these symptoms in end
stage COVID-19 can be alleviated with low doses of
opioids and benzodiazepines, delivered subcutaneously
with a battery operated syringe driver.8,9,20,21 Palliative
care has expertise in holistic end of life care, care for
older people and those with multimorbidity.22 This
flexibility, expertise and learning will be crucial to the
international response to COVID-19, especially as cases
of COVID-19 continue to rise across the globe.
Our study identified three different groups of
patients, and these may require different approaches. A
parallel planning approach may be needed for patients
with uncertain trajectories, as is often used among
patients with other uncertain prognosis in serious ill-
ness.23,24 Parallel planning provides for two sets of plans,
run side by side. Both plans aim to ensure symptom
management and the best in care: one plan is towards
improvement or recovery, the second plan is in case the
patient deteriorates or begins to die.24 Parallel plans
may lessen concerns about care rationing and communi-
cation, which emerged from public consultation.25
Despite efforts to respond and their resilience, palli-
ative care services reported considerable shortages of
PPE, staff, medicines and other equipment. PPE short-
ages especially affected charity managed services.
Almost half of services were charity managed; these
had lower levels of integration with national health sys-
tems than publicly managed services. It is six years since
the World Health Assembly resolution in 2014, called
for better integration of palliative care into health care
systems; a declaration endorsed by all countries.26 Our
findings reveal little progress. Most countries of the
globe lack palliative care doctors, nurses, allied health
professionals and trainees to meet their needs.27,28
Undergraduate doctors and nurses receive scant train-
ing in palliative care, leaving them lacking in confidence
and skills in symptom management, communication
and care.29,30 Undergraduate and postgraduate training
from expert palliative care clinicians is urgent, as well as
developing an adequate palliative care workforce to sup-
port services and patients day-to-day, especially as
COVID-19 surges continue.
Home nursing and inpatient palliative care units
were most seriously affected by PPE shortages. This
continued even in the seven days before survey comple-
tion, especially in the UK. Many palliative care patients
chose not to come to hospital, preferring care at home
for fear of contracting COVID-19 and/or wishing to
remain close to those important to them, a result sup-
ported by research in other pandemics.12,31 and data
from the first wave of the COVID-19 pandemic.32
Taken together these findings are concerning. If
patients are to remain in the community, then the com-
munity and care homes, as well as hospitals, need suffi-
cient resources to be able to provide care; this includes
Personal Protective Equipment, syringe drivers to
deliver subcutaneous infusions to control symptoms
and sufficient (and as we moved forward, adequately
vaccinated) staff and medicines. Legislation on the
reuse of medicines in the community, especially at
times of shortages, may need to be revised. The role of
free standing inpatient palliative care units during pan-
demics is worthy of consideration and planning: could
their staff proactively be diverted to the community (as
occurred in many settings in our study), could they be
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diverted to hospital palliative care teams or care homes
(both settings needing additional support), or could
they provide an alternative or rehabilitation/step down
care from hospitals? Any option would need planning,
training, and possibly a different skill mix.
Limitations and Strengths
The findings of this study are limited by its cross-sec-
tional design; causal relationships cannot be confirmed.
There may be nonresponse, sample and other biases.
We do not know whether services who did not respond
had different experiences, with more or fewer chal-
lenges. The survey was distributed through networks
known to us, mainly UK and European. (Although
approached, some other countries, e.g., Australia, were
unable to distribute the survey to palliative care net-
works.) The survey was offered only in the English lan-
guage; most responses were from the UK. Some
countries were not represented, or had few responses.
Country level effects and clustering may be important,
we did not have sufficient data to explore this. At the
time of the survey the pandemic was affecting regions
differently, which might have affected responses. These
limit the interpretation of our international compari-
sons. Responses may have been influenced by social
desirability. Free-text comments are a useful source of
information,.33, but may not represent all respondents.
Nevertheless, this is the first study to provide systematic
multinational data on the palliative care response and
challenges faced during the COVID-19 pandemic. We
used a combination of networks to try to obtain a wide
response; there is no comprehensive multinational net-
work of palliative care services from which we could sam-
ple. We combined closed and free text responses to
generate in depth findings that supported, shed further
light on and complemented the findings from closed
responses, providing a more robust, detailed and inclu-
sive response than earlier surveys.
Conclusion
Palliative care services responded actively but most
felt ignored by national health systems during the
COVID-19 pandemic, despite supporting patients who
were dying or had severe symptoms, supporting their
families/carers, and supporting other professionals to
deliver care. Services provided expertise in symptom
management and holistic care while facing shortages
of equipment, staff and medicines. The crucial role of
palliative care during pandemics must be better recog-
nized and integrated. This is particularly the case for
charity managed services and those providing care in
people’s homes. Beyond COVID-19, this research has
shed light on the limited integration of palliative care,
the urgent need to increase its workforce and a need
for palliative skills to be a core part of the training of
clinicians.
Copyright
The CovPall Questionnaire is copyright. License
for use of the questionnaire is granted free of charge.
However, you may not charge for use of the question-
naire. All reproductions of the questionnaire should
contain the statement: “Reproduced with the permis-
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Palliative Care, Policy and Rehabilitation, King’s Col-
lege London, on behalf of the CovPall Study Team, as
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should be referenced, and permission for use of the
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Data Sharing
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for data access should be addressed to the Chief Investi-
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